CV


Abstract: Personal Information : Name: Maassoumeh Surname: Akhlaghi Kalahroodi Marital status : Married Nationality: Iranian Birth Date: March17.1966 Country of Birth:Iran City of Birth : Tehran Address: Rheumatology Research Center, Shariati hospital , Tehran.Iran Phone Number: +982188026956 Email Address: Akhlaghimd@yahoo.com Professional membership: • Assistant Professor of Rheumatology in Rheumatology Research Center –Tehran University of Medical Sciences since 2005 • A member of the internal medicine research association in Shariati hospital since 2007 • A member of the Rheumatology research center –Tehran university of medical sciences • A member of Iranian Rheumatology association • A member of Asia and Pacific region rheumatology association (APLAR) Education: • Medical School: Mashad University of Medical Sciences, Mashad, 1984-1991 • Internal Medicine training: Mashad University of Medical Sciences, Qaem Hospital, Mashad, 1996-2000 • Rheumatology training: Tehran University of Medical Sciences, Shariati Hospital, Rheumatology Research Center, Tehran, 2001-2003. Attended workshops: • Scientific writing (Elementary and Advanced) • Research methodology (Elementary and Advanced) • Educational process in medical sciences • PowerPoint • Bone Densitometry • Bone Ultrasonography • How to hold a better bedside teaching • Ethics in Research • Medical Ethics congress Publications-Books: • Musculoskeletal involvement in thyroid disease( book title: metabolic disorders and joints and bone ,printed Feb2005) • Physiotherapy (book title: Rheumatic diseases ,printed Feb2006) • Muscle anatomy, physiology and Biochemistry (book title: Connective tissue disorders ,printed Feb2007) • Connective tissue disorders associated with HIV infection (book title: osteoarticular diseases and infections ,printed Feb2008) • Gene therapy in rheumatic disease (book title: novel challenges in rheumatology ,printed Feb2009) • Reactive arthritis (book title: children’s rheumatic disease ,printed Feb2010) • The role of environmental factors in systemic lupus erythematosus(book title: systemic lupus erythematosus, printed Feb2011) • Ethiologic factors in Osteoarthritis(book title: Osteoarthritis ,printed Feb2012) • Book title: Osteoarthritis ,printed Feb2012 • Fibrosing syndromes: Scleroderma ,printed Feb 2013 Publications-Internal and External articles: • Cyclophosphamide in Patients with Ocular Lesions of Behcet's Disease. Iran J Med Sci 2005; 30(3) • How much improvement is expected in ocular lesions of Behcet’s disease treated with puls cyclophosphamide?. Iranian J of Med Sci. September 2005; 30(3):101-104 • Management of ocular manifestations of Behcet’s disease: outcome with cytotoxic drugs.APLAR Journal of Rheumatology. 2005; 8(2),119-123 • Performance of Existing Diagnosis/Classification Criteria for Behcet’s Disease in Iranian Patients: Analysis of 5666 Patients and 2406 Controls. Aplar Jurnal of Rheumatology 2006; 9:238-243 • Serum level of triglyceride ,high density lipoprotein ,tumor necrosis factor –alpha and its receptor solubility with Systemic Lupus Erythematosus activity. Sci j zanjan Univ Med scinces. 1385;14(54):1-9 • Pathergy test in Behcet's disease: change in incidence over the time. APLAR Journal of Rheumatology. 2007; 10: 333-335 • Prevalence of Behcet's disease in Iran: a WHO-ILAR COPCORD stage I study. APLAR Journal of Rheumatology 2007; 10: 239-243 • Triglyceride and high-density lipoprotein levels as the markers of disease activity and their association with TNF-α and TNF receptor system in systemic lupus erythematosus. APLAR Journal of Rheumatology 2008; 10: 221-226 • HLA-B51 in Behcet's Disease. Acta Medica Iranica 2008;46(6):507-510 • Clinical Hand Osteoarthritis in Tehran: Prevalence, Signs, Symptoms, and Pattern - COPCORD Stage I, Iran Study. J Rheumatol., 2008; 35(7):1467-8 • The Prevalence of Oral Aphthosis in a Normal Population in Iran: A WHO-ILAR COPCORD Study. Archives of Iranian Medicine, 2008; 11(2):207-9. • WHO-ILAR COPCORD Study (Stage 1, Urban Study) in Iran. J Rheumatol, 2008; 35(7):138 • WHO-ILAR COPCORD Study (Stage 1, Urban Study) in Iran. J Rheumatol, 2008; 35(7):138 • Assessment of Serum Throbomodulin in Patients with Systemic Lupus Erythematosus in Rheumatology Research Center. Acta Medica Iranica, 2009; 47(2):97-102 • The prevalence of symptomatic hand osteoarthritis in Tehran: Community-oriented program for Control of Rheumatic Diseases- COPCORD. Tehran University Medical Journal (TUMJ), 2009; 67(6) : 443-449 • Nailfold capillaroscopy in Behcet's disease, analysis of 128 patients. Clinical Rheumatology 2009; 28: 603-605 • Effect of Ethnic Origin (Caucasians versus Turks) on the Prevalence of Rheumatic Diseases: a WHO-ILAR COPCORD Urban Study in Iran. Clinical Rheumatology, Nov 2009; 28(11):1275-82. • Isolated Hematuria in SLE Patients and its Association with Proteinuria, Urinary Cast and SLE Disease Activity.Acta Medica Iranica, 2009; 47(1):5-8 • Behcet’s disease: from east to west. Clin Rheumatol. 2010 Aug;29(8):823-33. • Cytokines genetic polymorphism in rheumatoid arthritis and their impact on radiologic erosions: study of gene polymorphism of TNF-α, IL-4, IL-6, TGF-β & IFN-γ. International Journal of Rheumatic Diseases, 2010; 13 (suppl. 1):1-11 • Behcet’s disease in Iran: analysis of 6500 cases. Int J Rheum Dis. 2010 Oct;13(4):367-73. • How to deal with Behcet's Disease in daily practice. International Journal of Rheumatic Diseases, 2010; 13 (suppl. 1):105-116 • Rituximab in intractable ocular lesions of Behcet’s disease; randomized single-blind control study (pilot study).Int J Rheum Dis. 2010 Aug;13(3):246-52. • Systemic lupus erythematosus in Iran: a study of 2280 patients over 33 years. International Journal of Rheumatic Diseases 2010 Oct;13(4):374-9 • Validation of the International Criteria for Behcet’s Disease (ICBD) in Iran. International Journal of Rheumatic Diseases, 2010; 13:55-60 • Behcet’s disease: from east to west. Clin Rheumatol. 2010 Aug;29(8):823-33. • Gender influence on ocular manifestations and their outcome in Behcet’s Disease. A long-term follow-up of up to 20 years. Clin Rheumatol. 2011 Apr;30(4):541-7. • Behcet’s disease: is there a gender influence on clinical manifestations? International Journal of Rheumatic Diseases 2011 • Diagnostic value of pathergy test in Behcet's disease according to the change of incidence over the time. Clin Rheumatol. 2011 Sep;30(9):1151-5. Epub 2011 Mar 2. • Behcet's disease: is there a gender influence on clinical manifestations? International Journal of Rheumatic Diseases 2012; 15: 306-314 • Association of programmed cell death-1 (PDCD-1) gene polymorphisms with rheumatoid arthritis in Iranian patients. Clin Exp Rheumatol. 2011 Sep-Oct;29(5):763-7. Epub 2011 Oct 31. • Clinical and preclinical manifestation of systemic lupus erythmatous. HUMJ. 2011; 15(1): 33-39 • Evaluation of apoptosis-related gene Fas (CD95) and FasL (CD178) polymorphisms in Iranian rheumatoid arthritis patients. Rheumatol Int. 2012 Sep;32(9):2833-6. doi: 10.1007/s00296-011-2065-x. Epub 2011 Aug 31. • Impact of the positive pathergy test on the performance of classification/diagnosis criteria for Behcet's disease. Mod Rheumatol. 2012 Apr 4. [Epub ahead of print] PMID: 22476858 • Endothelin-1 in systemic sclerosis.Indian Dermatol Online J. 2012 Jan;3(1):14-6. doi: 10.4103/2229-5178.93484. Projects: • Prevalence of Rheumatic Problems and diseases in Tehran • Evaluation of the TNF-a , IL-1 , IL-6 , IL-8 serum level in Behcet’s disease and its comparison with healthy individual • Evaluation of inflammatory and anti inflammatory cytokines polymorphism in Behcet‘s Disease • Evaluation And Validation Of The International Criteria For Behcet`s Disease, Revision And Creation Of A New International Diagnosis/Classification Criteria By An International Team From 30 Countries • Comparing the psychopathologic symptoms in patients with becet’s disease and control by using Symptom Check List-90-Revised (SCL-90-R) • The efficacy of back school on Low back pain and quality of life of workers of a pharmaceutics Company in Tehran suburb. (Stage III) Study COPCORD • Determination of prevalence of rheumatic complaints and diseases in village A (COPCORD) • Validity and reliability of WHO-ILAR COPCORD Core questionnaire for identification of Risk Factors for Knee Osteoarthritis • Rituximab in Ocular manifestations of Behcet’s DiseaseTNF alfaT CelB CelIL8(AECA) Anti Endothelial Cell Anti body (Pilot Study • Assessment of Cognitive Impairment in Behcet Patients Referring to Behcet’s Disease Clinic, Dr. Shariati Hospital in 2007 in Comparison with Control Group • Rituximab in Ocular manifestations of Behcet’s Disease (Pilot Study) • The efficacy of N-acetylcysteine ON the activity of behcet‘s disease in patients referring to behcet”s clinic , Shariati hospital ,2006 • Periungual Capillaroscopic Survey of Microvascular Involvement and its relation to other clinical manifestation in Patients with Behcet`s Disease Referring to Behcet`s Clinic,Shariati Hospital,2007 • The efficacy of cognitive behaviour therapy on quality of life of rheumatoid arthritis patients • Evaluation of a Programmed Death-1(PD-1) Gene Polymorphism With Rheumatoid Arthritis in Iranian Petients • prospective evaluation of musculoskeletal manifestations in patients with behcet disease in a 5 year period • Evaluation of IFN-γ, TNF-α, TGF-β, IL-4 and IL-6 polymorphisms effective on cytokines production in Rheumatoid Arthritis patient that visited in shariati hospital • Determination of PADI-4 Polymorphisms in patients of rheumatoid arthiritis Presentations: • Participating in 13th international congress of Behcet’s disease, Austria 2008:13 articles. • Participating in 13th international congress of rheumatology, APLAR, Japan 2008 :1 article. • Participating in 14th international congress of rheumatology, APLAR, Hong Kong 2010 :1 article. • Participating in international congress of Behcet’s disease, London 2010:3 articles. • Osteoarthritis congress, Ghom university of medical sciences • Osteoporosis , Kashan university of medical sciences • Crystal Induced arthritis and radiology(Gout), Iran Radiology association-Tehran • Participating in international congress of Behcet’s disease, Portugal 2006:8 articles. • Participating in 2011 ACR Annual Meeting in Chicago, Illinois, USA on November 4 – 9, 2011: 1 article. • 15th International Conference on Behcet's Disease; 13th -15th July 2012, Yokohama: 7 articles. • The 6th Annual Congress of Iran Rheumatology Association; 17 to 19 oct 2012, Shahaid Beheshti University of Medical Sciences, TEHRAN, IRAN: 1 article. • 2012 ACR Annual Meeting in Washington, DC, USA, November 9-14, 2012: 1 article. • The 15th Congress of Asia Pacific League of Associations for Rheumatology (APLAR); Dead Sea, Amman, Jordan, September 2012: 1 article.